Found: 37
Select item for more details and to access through your institution.
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 874, doi. 10.3390/vaccines12080874
- By:
- Publication type:
- Article
Green Routes: Exploring Protein-Based Virus-like Nanoparticle Transport and Immune Activation in Nicotiana benthamiana for Biotechnological Applications.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 831, doi. 10.3390/vaccines12080831
- By:
- Publication type:
- Article
Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00479-9
- By:
- Publication type:
- Article
Neutralization of MERS coronavirus through a scalable nanoparticle vaccine.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00365-w
- By:
- Publication type:
- Article
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-020-00264-6
- By:
- Publication type:
- Article
Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.864718
- By:
- Publication type:
- Article
The next generation virus‐like particle platform for the treatment of peanut allergy.
- Published in:
- Allergy, 2023, v. 78, n. 7, p. 1980, doi. 10.1111/all.15704
- By:
- Publication type:
- Article
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern.
- Published in:
- Allergy, 2022, v. 77, n. 8, p. 2446, doi. 10.1111/all.15311
- By:
- Publication type:
- Article
A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2.
- Published in:
- Allergy, 2022, v. 77, n. 1, p. 243, doi. 10.1111/all.15080
- By:
- Publication type:
- Article
In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion.
- Published in:
- Allergy, 2022, v. 77, n. 1, p. 111, doi. 10.1111/all.15065
- By:
- Publication type:
- Article
Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor‐binding domain mutations: Receptor affinity versus neutralization of receptor interaction.
- Published in:
- Allergy, 2022, v. 77, n. 1, p. 143, doi. 10.1111/all.15002
- By:
- Publication type:
- Article
BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced.
- Published in:
- Allergy, 2021, v. 76, n. 9, p. 2895, doi. 10.1111/all.14893
- By:
- Publication type:
- Article
Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity.
- Published in:
- Allergy, 2021, v. 76, n. 8, p. 2565, doi. 10.1111/all.14864
- By:
- Publication type:
- Article
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 661, doi. 10.3390/vaccines12060661
- By:
- Publication type:
- Article
Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant Approach.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 355, doi. 10.3390/vaccines12040355
- By:
- Publication type:
- Article
Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 743, doi. 10.3390/vaccines10050743
- By:
- Publication type:
- Article
Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 307, doi. 10.3390/vaccines10020307
- By:
- Publication type:
- Article
Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1316, doi. 10.3390/vaccines9111316
- By:
- Publication type:
- Article
A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1287, doi. 10.3390/vaccines9111287
- By:
- Publication type:
- Article
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 642, doi. 10.3390/vaccines9060642
- By:
- Publication type:
- Article
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 403, doi. 10.3390/vaccines9040403
- By:
- Publication type:
- Article
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 395, doi. 10.3390/vaccines9040395
- By:
- Publication type:
- Article
Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 72, doi. 10.3390/vaccines7030072
- By:
- Publication type:
- Article
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 37, doi. 10.3390/vaccines6030037
- By:
- Publication type:
- Article
Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.
- Published in:
- Vaccines, 2017, v. 5, n. 4, p. 32, doi. 10.3390/vaccines5040032
- By:
- Publication type:
- Article
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.
- Published in:
- Vaccines, 2017, v. 5, n. 2, p. 10, doi. 10.3390/vaccines5020010
- By:
- Publication type:
- Article
Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3895, doi. 10.3390/ijms24043895
- By:
- Publication type:
- Article
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines.
- Published in:
- Diseases, 2018, v. 6, n. 4, p. 107, doi. 10.3390/diseases6040107
- By:
- Publication type:
- Article
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01015
- By:
- Publication type:
- Article
Cover Image, Volume 12, Issue 1.
- Published in:
- WIREs: Nanomedicine & Nanobiotechnology, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1002/wnan.1610
- By:
- Publication type:
- Article
Virus‐like particles for vaccination against cancer.
- Published in:
- WIREs: Nanomedicine & Nanobiotechnology, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1002/wnan.1579
- By:
- Publication type:
- Article
Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 4, p. 505, doi. 10.1002/eji.201948355
- By:
- Publication type:
- Article
Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0177964
- By:
- Publication type:
- Article
The 3Ds in virus‐like particle based‐vaccines: "Design, Delivery and Dynamics".
- Published in:
- Immunological Reviews, 2020, v. 296, n. 1, p. 155, doi. 10.1111/imr.12863
- By:
- Publication type:
- Article
Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands—A Role for CCL2.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01679
- By:
- Publication type:
- Article
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT<sup>®</sup>).
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.594911
- By:
- Publication type:
- Article